Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
BPC-157 was flagged by the FDA in 2023 as a compound carrying potential safety risks for compounding pharmacies, then had that flag lifted in 2026 without ever being approved, leaving it in a genuine grey zone
doi:10.1177/0306312710395341
Benefits include improved bone health, enhanced immune system function, better mood regulation, and overall well-being
Frequently asked questions How much bacteriostatic water should I add to my vial
By pairing the synthetic pentadecapeptide with an L-Arginine protective buffer, the compound exhibits an exceptional oral bioavailability profile exceeding 90%
US$ 24.68
US$ 27.91
US$ 26.89
US$ 29.33
US$ 25.82
US$ 23.98
US$ 21.52
